When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. Serotonin transporter - Wikipedia

   en.wikipedia.org/wiki/Serotonin_transporter

   The serotonin transporter (SERT or 5-HTT) also known as the sodium-dependent serotonin transporter and solute carrier family 6 member 4 is a protein that in humans is encoded by the SLC6A4 gene. [5] SERT is a type of monoamine transporter protein that transports the neurotransmitter serotonin from the synaptic cleft back to the presynaptic ...

3. 5-HTTLPR - Wikipedia

   en.wikipedia.org/wiki/5-HTTLPR

   5-HTTLPR (serotonin-transporter-linked promoter region) is a degenerate repeat (redundancy in the genetic code) polymorphic region in SLC6A4, the gene that codes for the serotonin transporter. Since the polymorphism was identified in the middle of the 1990s, [ 1 ] [ 2 ] it has been extensively investigated, e.g., in connection with ...

4. Biology of depression - Wikipedia

   en.wikipedia.org/wiki/Biology_of_depression

   A 2003 study proposed that a gene-environment interaction (GxE) may explain why life stress is a predictor for depressive episodes in some individuals, but not in others, depending on an allelic variation of the serotonin-transporter-linked promoter region . [15]

5. Epigenetics of depression - Wikipedia

   en.wikipedia.org/wiki/Epigenetics_of_depression

   BDNF is involved in depression through its effects on serotonin. BDNF has been shown to promote the development, function, and expression of serotonergic neurons. [28] Because more active serotonin results in more positive moods, antidepressants work to increase serotonin levels.

6. Monoamine transporter - Wikipedia

   en.wikipedia.org/wiki/Monoamine_transporter

   It has been observed that the pathology of depression involves dysfunction of monoamine neurotransmitter circuits in the CNS, particularly of serotonin and norepinephrine. Selective serotonin reuptake inhibitors (SSRIs) are the most widely used antidepressant and include fluoxetine (Prozac), citalopram (Celexa), and fluvoxamine (Luvox). These ...

7. Development and discovery of SSRI drugs - Wikipedia

   en.wikipedia.org/wiki/Development_and_discovery...

   Monoamine oxidase inhibitors (MAOIs) and tricyclic antidepressants (TCAs) were the first drugs to be developed for the treatment of depression, dating back to the early 1950s. Because of their undesirable adverse-effect profile and high potential for toxicity , due to their non-selective pharmacological effects, strict regimens were needed for ...